Michael Nicks
Impact in
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects
-
- Osteoarthritis Treatment and Mechanisms
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 3
- PI3K/AKT/mTOR signaling in cancer 2
- Glutathione Transferases and Polymorphisms 2
- Peroxisome Proliferator-Activated Receptors 1
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 4
- Pulmonary Hypertension Research and Treatments 2
- Co-authors
- Russell P. Bowler (5 shared papers)Raphael A. Nemenoff (3 shared papers)Lynn E. Heasley (2 shared papers)Karl Skorecki (1 shared paper)Maureen M. O’Brien (1 shared paper)Elizabeth A. Regan (3 shared papers)James D. Crapo (2 shared papers)Roger M. Mason (1 shared paper)
- Journals
- Free Radical Biology and Medicine (2 papers)Biochemical and Biophysical Research Communications (1 paper)European Respiratory Review (1 paper)CHEST Journal (1 paper)COPD Journal of Chronic Obstructive Pulmonary Disease (1 paper)
- Partner nations
- United StatesNetherlandsFinland
In The Last Decade
Michael Nicks
11 papers receiving 471 citations
Peers
Comparison fields: 5 of 74
- Pharmacology 103
- Rheumatology 65
- Biochemistry 26
- Nephrology 22
- Cancer Research 45
Countries citing papers authored by Michael Nicks
This map shows the geographic impact of Michael Nicks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Nicks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Nicks more than expected).
Fields of papers citing papers by Michael Nicks
This network shows the impact of papers produced by Michael Nicks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Nicks. The network helps show where Michael Nicks may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Nicks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 149 | |
| 2 | 2005 | 121 | |
| 3 | 2011 | 51 | |
| 4 | 2014 | 44 | |
| 5 | 2010 | 42 | |
| 6 | 2011 | 27 | |
| 7 | 1998 | 18 | |
| 8 | Abnormal function of protein kinase C in cells having phosphatidylethanolamine-deficient and phosphatidylcholine-excess membranes. | 1993 | 15 |
| 9 | 1997 | 6 | |
| 10 | 2006 | 3 | |
| 11 | 2001 | 1 |
About Michael Nicks
Michael Nicks is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Immunology, Pharmacology and Health, Toxicology and Mutagenesis, having authored 11 papers that have together received 477 indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Pulmonary Hypertension Research and Treatments (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Glutathione Transferases and Polymorphisms (2 papers), Peroxisome Proliferator-Activated Receptors (1 paper), Osteoarthritis Treatment and Mechanisms (1 paper) and High Altitude and Hypoxia (1 paper). The work is most often cited by research in Pharmacology (103 citations), Rheumatology (65 citations), Biochemistry (26 citations), Nephrology (22 citations) and Cancer Research (45 citations). Michael Nicks has collaborated with scholars based in United States, Netherlands and Finland. Frequent co-authors include Russell P. Bowler, Raphael A. Nemenoff, Lynn E. Heasley, Karl Skorecki, Maureen M. O’Brien, Elizabeth A. Regan, James D. Crapo, Roger M. Mason, Harry F.G. Heijnen and B. Carbone. Their work appears in journals such as Free Radical Biology and Medicine, Biochemical and Biophysical Research Communications, European Respiratory Review, CHEST Journal and COPD Journal of Chronic Obstructive Pulmonary Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.